Hongtao Li

Jilin University — China

Medicine · Health Sciences

31h-index3.1kcitations221works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Sarcoma Diagnosis and Treatment(31), Radiopharmaceutical Chemistry and Applications(10), CAR-T cell therapy research(10), Gastric Cancer Management and Outcomes(9), RNA modifications and cancer(8)

Publications219 total

CD25 modulation enhances broadly neutralizing antibody response of SARS-CoV-2 subunit vaccine
Communications Biology·2026Open Access
Microenvironmental stiffness directs microtubule perturbation in chondrocyte mitosis via ILK-refilinB/Smad3 axis
Bone Research·2026Open Access
Resolution of Severe Jaundice Following Hepatic Artery Infusion of Bevacizumab and 5-Fluorouracil in Metastatic Colorectal Cancer: A Case Report
2025
Global burden of thyroid cancer attributable to metabolic risk factors in women of reproductive age (20–49 years): a GBD 2021 cross-national analysis with projections to 2050
BMC Women s Health·2025Open Access
Supplementary Table S3 from First-in-Maintenance Therapy for Localized High-Grade Osteosarcoma: An Open-Label Phase I/II Trial of the Anti–PD-L1 Antibody ZKAB001
2025Open Access
Supplementary Table S2 from First-in-Maintenance Therapy for Localized High-Grade Osteosarcoma: An Open-Label Phase I/II Trial of the Anti–PD-L1 Antibody ZKAB001
2025Open Access
Supplementary Figure S1 from First-in-Maintenance Therapy for Localized High-Grade Osteosarcoma: An Open-Label Phase I/II Trial of the Anti–PD-L1 Antibody ZKAB001
2025Open Access
Supplementary Table S1 from First-in-Maintenance Therapy for Localized High-Grade Osteosarcoma: An Open-Label Phase I/II Trial of the Anti–PD-L1 Antibody ZKAB001
2025Open Access
Supplementary Table S4 from First-in-Maintenance Therapy for Localized High-Grade Osteosarcoma: An Open-Label Phase I/II Trial of the Anti–PD-L1 Antibody ZKAB001
2025Open Access
Supplementary Table S5 from First-in-Maintenance Therapy for Localized High-Grade Osteosarcoma: An Open-Label Phase I/II Trial of the Anti–PD-L1 Antibody ZKAB001
2025Open Access
Transforming from non-responsive to responsive: A novel AIE strategy for HClO sensing
Microchemical Journal·2025· 1 cited
RAN Promotes Autophagy and Malignant Progression of Lung Adenocarcinoma through ATG101
Advanced Biology·2025
Injectable micropore-forming microgel scaffold for neural progenitor cells transplantation and vascularization after stroke
Nature Communications·2025· 2 citedOpen Access
The involvement of 5-HT was necessary for EA-mediated improvement of post-stroke depression
Translational Psychiatry·2025· 2 citedOpen Access
CLEC3A Promotes Immune Evasion and Tumor Progression by Enhancing PD-L1 Stability to Weaken T Cell Cytotoxicity in Luminal Breast Cancer
Breast Cancer Targets and Therapy·2025Open Access
Expression and regulation network of BLNK in CP/CPPS in animal, cell model and clinical samples
Inflammation·2025· 2 citedOpen Access
Rare complete replacement-type left hepatic artery originating from the left gastric artery: A case report
World Journal of Hepatology·2025Open Access
The impact of Stromal antigen 2 (STAG2) on migration and invasion of Hepatocellular carcinoma
2025Open Access
Molecular surveillance-informed personalized multidisciplinary therapy achieves prolonged survival in a patient with Lynch syndrome-associated colorectal cancer: A case report
World Journal of Gastrointestinal Oncology·2025Open Access
Train timetable synchronization optimization for subway–suburban rail transfer systems: A double-level discretization approach
Computers & Industrial Engineering·2025· 1 cited
page 1 of 11Next →

Frequent Co-authors

Zan Shen(10), Yang Yao(6), Yi Luo(5), Hui Zhao(5), Lina Tang(5), Xinmin Lai(4), Chengfeng Li(4), Jun Ni(4), Yanjun Han(4), Xiao‐Ou Shu(4), Aina He(4), Daliu Min(4), Wenjie Wang(4), Jianping Yu(4), Hongbin Liu(4), Shuier Zheng(4), Qingcheng Yang(4), R. Villegas(3), Gong Yang(3), Zhiyu Wang(3)